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Editorial
Ultrasound-guided corticosteroid injection in
rheumatology: accuracy or efficacy?
Is it the best way to deliver corticosteroid injections?
This editorial refers to ‘Steroid injection for hip
osteoarthritis—efficacy under ultrasound guidance’,
by Mihaela C. Micu et al., doi:10.1093/rheumatology/
keq030, on page 1490 and ‘Ultrasound-guided sacroi-
liac joint injection in patients with established sacroi-
liitis: precise IA injection verified by MRI scanning
does not predict clinical outcome’, by Wolfgang
Hartung et al., doi:10.1093/rheumatology/kep424, on
page 1479.
Two articles by Micu et al. [1] and Hartung et al. [2] in
this issue are interesting because they describe the
short-term efficacy of corticosteroid injection performed
with ultrasound (US) guidance for hip OA and sacroiliitis,
respectively. In the first study, on hip OA [1], 100% of
patients received correct IA needle placement and
showed significant clinical improvement compared with
the controls who did not receive the steroid injection. In
the other study on US-guided injections in sacroiliac joints
in patients with sacroiliitis [2], only 40% of the procedures
reached the synovial space when verified by MRI. While
this accuracy rate was lower than previously published
studies (which ranged from 80 [3] to 93.5% [4]), this
study interestingly reported no significant difference in
clinical improvement whether steroid was delivered into
the SI synovial space or merely the posterior periarticular
area of the SI joint. Clearly, more studies are needed to
provide evidence about short- and long-term benefit and
cost effectiveness of therapeutic US-guided injections vs
blinded injections.
When expert clinicians deliver IA injections, they normal-
ly do not need guidance from imaging techniques to place
the needle successfully in the target area. However, some
studies report variable accuracy in placement of the
needle in palpation-guided IA injections [5, 6]. To locate
the exact needle position in ‘blind’ injections is, of
course, difficult in deep joints (e.g. hip, SI or glenohumeral
joints). This fact might be clinically crucial for diagnostic IA
aspiration or when accurate IA medication injection is ne-
cessary (e.g. radioisotopes and viscosupplementation). In
addition, in conventional ‘blind’ routes, the risk of inciden-
tal damage to the adjacent non-target structures by the
needle or injected drug, or from both, cannot be avoided
completely. These structures include, depending on the
injected region, blood vessels, peripheral nerves, muscles,
ligaments, intratendinous tissue and subcutaneous fat.
Ultrasound is a valuable bedside tool for guiding accur-
ate and safe musculoskeletal fluid aspiration and injec-
tions [7]. Moreover, it confirms the clinical diagnosis and
the indication for injection. Real-time ultrasound enables
the rheumatologist to correctly place the needle, accur-
ately deliver medication and visualize the steroid suspen-
sion during and after the procedure. Epis et al. [7] have
described the accuracy, safety and simplicity of US for
guiding interventional procedures in the musculoskeletal
system. US-guided injections performed by clinicians are
as feasible as blind procedures in clinical practice.
However, there is a learning time for the correct use of
US-guided injections and the success of the technique is
operator dependent [3, 4, 8]. In particular, US-guided
injections of deep anatomical targets require more experi-
ence than superficial injections. The oblique direction of
the needle to the ultrasound beam in deep injections
decreases its visibility during these procedures. After
appropriate training, however, US guidance is suitable
for deep joints such as the hip and SI joints, and is
successful and effective [3, 9].
The effect of accurate needle placement in a therapeut-
ic response to local corticosteroid injection reported in the
literature needs further elucidation [2, 10]. Various argu-
ments can explain this controversy. The mechanism of
local steroid action is not well understood. Both a system-
ic effect and a local action by diffusion of the steroid sus-
pension either into blood vessels or the surrounding
anatomic structures could explain their therapeutic
effect, even when they do not reach the target tissue.
Nevertheless, a recent randomized controlled study by
Sibbitt et al. [10] on 148 painful joints clearly showed
that US guidance significantly improved the performance
and short-term outcome of IA steroid injections compared
with conventional palpation guidance. In conclusion,
we believe that US guidance can maximize injection
accuracy in the intended target area and minimize
adverse effects.
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